---
title: "TCRT.US (TCRT.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/TCRT.US/news.md"
symbol: "TCRT.US"
name: "TCRT.US"
parent: "https://longbridge.com/zh-HK/quote/TCRT.US.md"
datetime: "2026-03-10T10:33:07.336Z"
locales:
  - [en](https://longbridge.com/en/quote/TCRT.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TCRT.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TCRT.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/TCRT.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/TCRT.US/news.md)


# TCRT.US (TCRT.US) — 相關新聞

### [Weight Loss Data From Obese Mice Looks Promising For Alaunos Therapeutics, But Shares Drop](https://longbridge.com/zh-HK/news/277499466.md)
*2026-03-02T16:47:48.000Z*
> Alaunos Therapeutics Inc. (NASDAQ:TCRT) shares fell 3.13% to $3.09 after announcing promising preclinical data for its d

### [BUZZ-Alaunos rises as obesity‑drug data in mice shows weight loss](https://longbridge.com/zh-HK/news/277456760.md)
*2026-03-02T11:44:11.000Z*
> Shares of Alaunos Therapeuticsjump 18.8% to $3.79Drug developer says its experimental drug, ALN1003, helped obese mice l

### [Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders | TCRT Stock News](https://longbridge.com/zh-HK/news/277456677.md)
*2026-03-02T03:30:00.000Z*
> Alaunos Therapeutics, Inc. announced positive preclinical data for ALN1003, its lead oral treatment for obesity and rela

### [Oncotelic Therapeutics Issues 1.4 Million Warrants at $0.15 Exercise Price](https://longbridge.com/zh-HK/news/274206330.md)
*2026-01-29T21:31:45.000Z*
> Oncotelic Therapeutics Inc. has issued 1,422,613 warrants to purchase shares of its common stock at an exercise price of

### [Report: Roche's obesity research data is encouraging](https://longbridge.com/zh-HK/news/273807336.md)
*2026-01-27T07:57:38.000Z*
> Stefan Schneider of Vontobel pointed out in a research report that the mid-term study data for Roche's weight loss candi

### [Alaunos Updates Governance, Ends Cantor Advisory Agreement](https://longbridge.com/zh-HK/news/271945899.md)
*2026-01-08T13:58:12.000Z*
> Alaunos Therapeutics has terminated its advisory agreement with Cantor Fitzgerald and updated its bylaws to enhance stoc

### [Alaunos Therapeutics Terminates Engagement With Cantor Fitzgerald](https://longbridge.com/zh-HK/news/271943151.md)
*2026-01-08T13:46:15.000Z*
> Jan 8 (Reuters) - Alaunos Therapeutics Inc:* ALAUNOS THERAPEUTICS INC - TERMINATES ENGAGEMENT WITH CANTOR FITZGERALD - S

### [Alaunos Therapeutics Settles Outstanding Invoices with MD Anderson for $285,055](https://longbridge.com/zh-HK/news/270660432.md)
*2025-12-23T22:19:13.000Z*
> Alaunos Therapeutics Inc. has settled disputes with The University of Texas M.D. Anderson Cancer Center over unpaid invo